Clinical Trials Logo

Pacemaker Ddd clinical trials

View clinical trials related to Pacemaker Ddd.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06094114 Completed - Bradycardia Clinical Trials

Evaluation of VDD Leadless Pacing System During Exercise

Start date: April 1, 2022
Phase:
Study type: Observational

The study is a non-randomized, active prospective observational study permitting to report the behavior of Micra AV pacemaker during an exercise. Only patients who were previously implanted with a Micra MC1AVR01 can be enrolled in the study. Exercise test is part of the standard clinical care practice for this patients population during the first year follow-up.

NCT ID: NCT06068699 Completed - Adherence, Patient Clinical Trials

Postcards to Improve Remote Monitoring Adherence Among Veterans

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

We tested the effect of informational postcards on improving remote monitoring adherence among Veterans with pacemakers and implantable cardioverter-defibrillators in a stepped-wedge randomized controlled trial.

NCT ID: NCT05222672 Completed - Pacemaker DDD Clinical Trials

Electrical and Mechanical Activation in PAcing The His Bundle Conduction sYstem

EMPATHY
Start date: February 1, 2021
Phase:
Study type: Observational

In recent years, the finding of long-term deleterious effects of right ventricular pacing (RVP) has led to an ongoing search for alternative pacing sites such as His bundle stimulation. The depolarization of the ventricles through the His-Purkinje cardiac conduction system seems to represent an ideal physiological approach to ventricular pacing, capable of engaging the normal conduction pathways and determining synchronous ventricular activation. However, there are still no clinical studies that have evaluated the electromechanical functions of the left ventricle with His bundle pacing (HBP) identified after electroanatomical reconstruction with 3D mapping system. Investigators aimed to compare the electromechanical effects on left ventricle of HBP, compared to RVP stimulation and to spontaneous rhythm of each patient.

NCT ID: NCT04957771 Completed - Pacemaker DDD Clinical Trials

Effect of Standardized Exercise on Cardiopulmonary Function in Patients With Permanent Pacemaker Implantation

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to observe the changes of cardiopulmonary endurance in patients with pacemaker implantation after long-term exercise, to explore the significance of exercise on patients with pacemaker implantation, and to analyze the difference of the effect of exercise on cardiopulmonary endurance in patients with normal LVEF of different pacing ratios

NCT ID: NCT04372654 Completed - Coronary Disease Clinical Trials

Pilot Study Evaluating the Safety of Electroducer Sleeve Medical Device for Temporary Cardiac Stimulation During Percutaneous Cardiovascular Interventions, in All Kind of Patients

Start date: July 28, 2020
Phase: N/A
Study type: Interventional

During percutaneous cardiovascular intervention, temporary cardiac stimulation may be required. Usually this stimulation is generated via a temporary pacing catheter. In order to reduce the complexity of the procedure, a new stimulation strategy has been developed: the "Direct Wire Pacing technique".In this approach, the cardiac stimulation is provided via the guidewire connected to an external pacemaker. Previous study demonstrated the superiority of the new technique compared to the former. However this technique is likely to generate electrical pain, risk of bleeding for the patient and risk of blood exposure accident for the operators. This is why the medical device ELECTRODUCER SLEEVE has been developed. This device integrates a pacing function to the introducer and the guidewire used. The "Direct Wire Pacing technique" is simplified, secured and more reproducible.

NCT ID: NCT04323670 Completed - Pacemaker DDD Clinical Trials

Master Study Investigating the Guiding Catheter Selectra 3D

Start date: October 8, 2020
Phase: N/A
Study type: Interventional

Study investigating the guiding catheter Selectra 3D

NCT ID: NCT04269733 Completed - Clinical trials for Atrioventricular Block

Risk of Pacing-induced Cardiomyopathy

Start date: May 1, 2020
Phase:
Study type: Observational

This study will evaluate the association between right ventricular pacing and the risk of pacing-induced cardiomyopathy.

NCT ID: NCT04163965 Completed - Pacemaker DDD Clinical Trials

Data Collection for Pacemaker Recognition Through Capacitive ECG

HSM-cECG
Start date: November 13, 2019
Phase: N/A
Study type: Interventional

This study evaluates the signal quality of capacitive ECG (cECG) on pacemaker patients and whether paced rhythms of the pacemaker can be distinguished from the normal beats using cECG signals.

NCT ID: NCT04067024 Completed - Pain Clinical Trials

Evaluation of the Effectiveness of the Supraclavicular Block Associated With a Pecs Blocks I to Ensure Analgesia When Placing a Pacemaker

Start date: January 18, 2017
Phase: N/A
Study type: Interventional

Pacemakers are currently placed at the Erasmus Hospital under local anesthesia performed by the surgeon, and the amount of local anesthetic agents sometimes reach the maximum permitted doses, with a risk of systemic toxicity. Moreover, these patients often present an associated conduction block. This represents a contraindication/constraint in the use of lidocaine 2% (local anesthesia frequently used by the surgeon to infiltrate). This study hypothesized that using a block of the supraclavicular nerve associated with a Pecs Block I. guided by ultrasound should require a smaller quantity of local anesthetic.

NCT ID: NCT03727542 Completed - Aortic Aneurysm Clinical Trials

Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels

Start date: October 15, 2018
Phase: N/A
Study type: Interventional

As potential biomarkers of pressure-related aortic damage, matrix metalloproteinases (MMP) have been implicated in the pathogenesis of aortic aneurysm because of the important role they play in connective tissue homeostasis. In particular, a significant reduction in initially elevated serum MMP - 9 concentrations, compared with healthy controls, demonstrated after the aortic repair in patients with abdominal aortic aneurysm implies MMPs pivotal role in aortic aneurysms. Besides, due to an active degradation and repair processes taking place in the vascular wall governed by the balance between MMP enzymes and their inhibitors, MMP - 9, expression of which is predominantly associated with disruption of aortic elastic fibers, can also be detected in the serum of healthy subjects. Indeed, mechanical stress-induced upregulation of genes and their products stimulate MMP expression in the vascular wall, which is responsible for extracellular matrix degradation. Herein, it was hypothesized that reducing the acceleration rate of aortic pressure (aortic peak dP/dt) may decrease the mechanical stretch on the aortic wall which, may in turn, reduce the expression and serum levels of MMP-9.